Acurx Pharmaceuticals Inc.

09/12/2026 | Press release | Distributed by Public on 09/12/2026 08:15

“Comparative In Vitro Killing Kinetics of Ibezapolstat and Comparator Antibiotics in Clostridioides difficile and Vancomycin-resistant Enterococcus Co-Cultures” dated September[...]

Acurx Pharmaceuticals Inc. published this content on September 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 12, 2026 at 14:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]